Your session is about to expire
← Back to Search
Investigational Device for Parkinson's Disease (LIGHT-PD Trial)
N/A
Recruiting
Led By Ray Dorsey, MD
Research Sponsored by PhotoPharmics, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Stable levodopa and other anti-PD medications for at least 28 days prior to screening
Diagnosis of Parkinson's disease as determined by the study PI, in keeping with the UK PD Society Brain Bank Criteria for the Diagnosis of PD
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 26 weeks
Awards & highlights
LIGHT-PD Trial Summary
This trial will help researchers understand if light therapy can improve movement and non-movement symptoms in Parkinson's disease, in addition to current medical treatment.
Who is the study for?
This trial is for people with Parkinson's Disease who respond to dopaminergic medication, have been on treatment for at least a year, and have relatively good eyesight (corrective lenses are okay). They must be stable on their current Parkinson's medications for at least 28 days before the study starts.Check my eligibility
What is being tested?
The trial is testing if a Celeste Specialized Phototherapy Device can improve both movement and non-movement symptoms in those with Parkinson’s Disease when used alongside their regular medications.See study design
What are the potential side effects?
Potential side effects of the phototherapy device may include eye strain or discomfort, headache, sleep disturbances or mood changes. However, specific side effects will be monitored throughout the trial.
LIGHT-PD Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My Parkinson's medication doses have been stable for the last 28 days.
Select...
I have been diagnosed with Parkinson's disease by a study leader.
LIGHT-PD Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 26 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~26 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Parkinson's Disease Questionnaire-39 (PDQ-39)
Secondary outcome measures
Movement Disorders Society-Unified Parkinson's Disease Rating Scale, Sum or Parts 1+2
Other outcome measures
Beck Anxiety Scale (BAI)
Beck Depression Inventory -II (BDI-II)
Epworth Sleepiness Scale (ESS)
+8 moreLIGHT-PD Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: Investigational DeviceActive Control1 Intervention
The Celeste device resembles a large tablet. It has a protective cover that folds into a stand and is magnetically attached to the back of the device. It produces a low intensity of specific bandwidths of light believed to be responsible for circadian and alerting responses in humans. The overall emission produces a pleasing soft glow of light.
Group II: Control DevicePlacebo Group1 Intervention
The Control device is identical in appearance to Celeste. When turned on, the device emits a soft diffused light that is indistinguishable in color from the Active Device. However, this device produces a different amount of the specific wavelengths thought to be effective in the Active Device. It is impossible to tell the difference between the sham device and the active device by looking at them.
Find a Location
Who is running the clinical trial?
University of RochesterOTHER
840 Previous Clinical Trials
533,950 Total Patients Enrolled
PhotoPharmics, Inc.Lead Sponsor
2 Previous Clinical Trials
172 Total Patients Enrolled
Ray Dorsey, MDPrincipal InvestigatorUniversity of Rochester
1 Previous Clinical Trials
10 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this medical study currently open for enrollment?
"According to clinicaltrials.gov, this specific study is currently not enrolling new participants. The trial was initially posted on February 21st, 2024 and last updated on February 20th, 2024. Despite the inactivity of this particular study, there are numerous other trials seeking candidates with a total of 520 actively recruiting at present."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger